Astera Labs CEO Files Intent to Sell $35.85 Million in Common Stock
ALAB has more than doubled off its 52-week low of $47.125.
Summary
Astera Labs' CEO, Jitendra Mohan, has filed a Form 144 indicating an intent to sell 281,250 shares of common stock, valued at approximately $35.85 million.
Key Events · Ownership and Investor Activity · ALAB
-
CEO Files Intent to Sell Shares
Jitendra Mohan, CEO and Director of Astera Labs, has filed a Form 144 to sell 281,250 shares of common stock.
-
Significant Proposed Transaction Value
The proposed sale has an approximate market value of $35,853,750.00, representing a material transaction for a C-suite executive.
-
Follows Recent Insider Sales
This filing follows previous sales by Jitendra Mohan of 94,971 shares in the past three months, with gross proceeds of $11,758,145.75.
Analysis · ALAB · Manufacturing
This Form 144 filing signals a significant intent to sell by Astera Labs' CEO, Jitendra Mohan. The proposed sale of approximately $35.85 million in common stock represents a notable transaction for a key executive. While the company has seen a pattern of Form 144 filings recently, a sale of this magnitude from the CEO could be interpreted by investors as a lack of confidence or a move to diversify holdings. Investors should monitor any subsequent Form 4 filings to confirm if these shares are actually sold and at what price. This follows a period of net insider distribution for the company.
How filings like this one have moved
In the 30 days to Sep 23, 2026, 29.1% of the 1683 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.32%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALAB was trading at $128.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $21.7B. The 52-week trading range was $47.13 to $262.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.